$106.60
0.510.48%
At close: Jul 17, 5:00 PM EST
$106.60
N/A
After Hours: 4:00 PM EST
Rhythm Pharmaceuticals Inc Earnings Estimates
RYTMNASDAQ
Rhythm Pharmaceuticals Earnings Estimates, EPS & Revenue | NASDAQ:RYTM
Rhythm Pharmaceuticals (RYTM) is scheduled to report Q2 earnings on August 4, 2026. Analysts estimate EPS of $-0.84 and quarterly revenue of $67.20M.
In the most recent quarter (Q1), Rhythm Pharmaceuticals reported EPS of $-0.83, beating estimates of $-0.86 by 0.03%. Revenue came in at $60.11M, exceeding the estimate of $56.16M by 0.07%.
Rhythm Pharmaceuticals has beaten EPS estimates in 2 consecutive quarters.
Over the last 4 quarters, Rhythm Pharmaceuticals has averaged an EPS surprise of 0.09% and a revenue surprise of 0.06%.
Earnings Date
Aug 4
EPS Estimate
$-0.840
Quarterly Revenue Estimate
$67.20M
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$217.16M
Rhythm Pharmaceuticals Earnings History
Analyze the earnings history of Rhythm Pharmaceuticals using advanced sorting and filters.
Loading calendar...
Rhythm Pharmaceuticals (RYTM) Earnings Per Share
The chart below shows Rhythm Pharmaceuticals's reported EPS compared to analyst estimates over recent quarters.
Rhythm Pharmaceuticals (RYTM) Revenue
The chart below shows Rhythm Pharmaceuticals's reported revenue compared to analyst estimates over recent quarters.
FAQ
When is Rhythm Pharmaceuticals (NASDAQ:RYTM) reporting earnings?
Rhythm Pharmaceuticals (RYTM) is scheduled to report earnings on August 4, 2026. The last reported earnings were for reported on May 5, 2026 for Q1.
What were the latest earnings per share (EPS) for Rhythm Pharmaceuticals (NASDAQ:RYTM)?
The Actual EPS was $-0.83, which beat the estimate of $-0.86.
What were Rhythm Pharmaceuticals’s (NASDAQ:RYTM) revenues?
The Actual Revenue was $60.11M, which beat the estimate of $56.16M.
